Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Altria Group's monstrous dividend yield is nearly 9%.

Searching for Huge Passive Income? Buy This Dividend King

British American Tobacco

For 4 years, we've preferred MO to BTI. But following the ban of IQOS in the US, the failure of JUUL to succeed, and the stagnating oral tobacco segment, I am forced to reconsider our position.

Altria Vs. British American Tobacco: If I Had To Pick One

A. O. Smith

Enbridge

First of Long Island

Fresenius Medical Care

Federal Realty Investment Trust

Gorman-Rupp

Lowe's

National Fuel Gas

Polaris

Stanley Black & Decker

Black Friday is a time to gorge on the world's best blue-chip bargains, not just left-over turkey. Today FMS, PII, MO, SWK, LOW, AOS, GRC, NFG, FLIC, ENB, and FRT represent the best Black Friday dividend deals on Wall Street.

11 Black Friday Dividend Aristocrat Deals

The case for Altria is intriguing for a certain type of investor, but it is not without risk.

1 Green Flag for Altria Stock, and 1 Red Flag

Coterra Energy

ONEOK

Simon Property Group

AT&T

Vale S.A.

Vornado Realty Trust

Verizon

In a logical world, one would think, with the Federal Reserve raising interest rates all year long, that rates across the entire Treasury yield curve would head higher.

With Inflation and Interest Rates Falling, 8 Blue Chips With Huge Dividends Are ‘Strong Buys'

Intel

Macy's

There are many misconceptions about dividend stocks. The conventional wisdom is that dividend stocks are safe investments that provide shareholders with a steady and reliable income stream.

3 Dividend Stocks to Sell Right Now

Altria Group, Inc. narrowed its EPS guidance for FY 2022. Capital returns and dividend growth are good reasons to buy Altria.

Why I Am Buying 8.5% Yielding Altria

A recent UBS downgrade is nothing new for Altria Group investors. At $38, Altria Group stock should be a steal on so many levels.

Altria: Ridiculous Downgrade

Juul Labs, which is partially owned by tobacco giant Altria (NYSE: MO ), is making headlines after receiving an investment from two early investors and initiating layoffs. As part of a cost savings and reorganization plan, Juul will lay off 400 employees in an attempt to reduce its operating budget by 30% to 40%.

Juul Labs Layoffs 2022: What to Know About Juul Job Cuts, Bankruptcy Fears

Juul Labs is slashing hundreds of jobs as the embattled company deals with a flood of lawsuits and increasing competition in the e-cigarette market.

Juul slashes 400 jobs as embattled vaping company faces growing setbacks

Juul Labs said it secured a financial lifeline as it aims to cut jobs and operating costs in a bid to avoid bankruptcy.

Juul reaches financing deal, plans to cut 30% of jobs to dodge bankruptcy

Juul Labs Inc. has secured a cash infusion from some of its early investors to stave off bankruptcy and plans to lay off about a third of its global staff, company officials said.

Juul secures financing to avoid bankruptcy and plans to cut 30% of jobs globally

The vaping company says it will lay off about 400 people after getting a bailout from board members.

Juul Secures Financing to Avoid Bankruptcy, Plans to Cut 30% of Jobs

W.W. Grainger

Leggett & Platt

MSA Safety

Nordson

Sysco

Target

Tennant

The 48 Dividend Kings finished October with a nice gain, collectively up 10.85%. Last month, the 11 best dividend kings based on forecasted growth and valuation underperformed the average dividend king return by 55 bps.

My 11 Best Dividend Kings For November 2022

The Marlboro maker has few good options left now that Philip Morris's game-changing $16 billion takeover of Swedish Match has sufficient shareholder support to proceed.

Altria Looks Like a Smoker Struggling to Quit

Altria's JV with Japan Tobacco attempts to address its strategic pivot on juicing growth again as JUUL has underperformed significantly. However, analysts remain unconvinced. Despite that, MO has outperformed the market significantly since our previous Buy rating in September, as we urged investors to add.

Altria: Don't Lift Your Hopes Too High From Here

The tobacco giant is taking its third bite at the electronic cigarette apple.

Could This Major Development Be a Game Changer for Altria Stock?

Devon Energy

Diamondback Energy

Lumen Technologies

Pioneer Natural Resources

V.F.

Treasury I Bonds used to be the best place going to get a big yield. But now they're getting a run for their money from the S&P 500.

9 Giant Stocks Now Pay Out More Than Treasury I Bonds

While we have seen a monster rally run into some trouble in November, the reality is that the Federal Reserve likely will raise interest rates by yet another 75 basis points, which will lift the federal funds to 3.75% to 4.00%.

6 Surprising ‘Strong Buy' Blue Chips With Fat 5% and Higher Dividends

Altria released weak Q3 results last Thursday, with cigarette volume down 10% and half of its 4.9% EPS growth from buybacks. We can look past the decline as driven by macro headwinds and a reversal of COVID benefits, not Reduced Risk Products.

Altria: Temporary Q3 Weakness, Permanent Strategic Missteps

Amgen

Avista

Conagra Brands

City Hld

CVB Financial

First Horizon National

Flowers Foods

General Mills

Kellogg

Kraft Heinz

Mercury General

Merck

Newmont Mining

Northwest Bancshares

NorthWestern

Safety Insurance

Tyson Foods

Investors cheered when a report last week showed the economy expanded in the third quarter after back-to-back contractions.

20 dividend stocks that may be safest if the Federal Reserves causes a recession

Icahn Enterprises

Vanilla investors are selling. Which means we income-focused contrarians are buying.

16 Yields That Are Too Big To Ignore

Altria faces challenges on three fronts. Earnings estimates are likely way too optimistic for the problems it has.

Altria: Earnings Estimates Look Optimistic

News for Altria Stock (MO)